Related Experiment Video
Updated: Jun 13, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA and drug resistance
1Department of Hematology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Cancer Gene Therapy
|May 15, 2010
Summary
MicroRNAs (miRNAs) play a crucial role in cancer chemotherapy resistance. Understanding miRNA dysregulation is key to overcoming drug resistance and improving long-term cancer treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemotherapy is a primary cancer treatment, but drug resistance limits its effectiveness.
- Mechanisms like gene mutation and epigenetic changes contribute to chemoresistance.
- MicroRNAs (miRNAs) are implicated in the development of drug resistance.
Purpose of the Study:
- To review the functions of miRNAs in the development of cancer drug resistance.
- To elucidate the role of miRNA dysregulation in chemoresistance.
Main Methods:
- Literature review of studies analyzing miRNA expression in chemoresistant vs. chemosensitive cancer cells.
- Examination of molecular targets and mechanisms of chemoresistance mediated by miRNAs.
Main Results:
- Differential expression of miRNAs is observed between chemoresistant and chemosensitive cancer cells.
- miRNAs are regulators of gene expression involved in chemoresistance.
- Specific miRNAs, like miR-125b, are suggested to be involved in drug resistance development.
Conclusions:
- miRNAs are significant regulators in the development of chemotherapy resistance.
- Further research into miRNA functions can elucidate mechanisms of chemoresistance.
- Targeting miRNA pathways may offer strategies to overcome drug resistance in malignancies.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...